Announcements Trials
Browse Landscape

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 19Observational 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioma 3Brain Neoplasms 2Pituitary Neoplasms 1Non-Melanoma Skin Cancer (NMSC) 1Neuroectodermal Tumors 1Neoplasms, Neuroepithelial 1Neoplasms 1Neoplasm, Residual 1Keratosis, Actinic 1Central Nervous System Neoplasms 1

Interventions

Surveys and Questionnaires 15Radiosurgery 14Magnetic Resonance Imaging 11Magnetic Resonance Spectroscopy 10Neuropsychological Tests 8Radiotherapy 7Radiation 4Blood Specimen Collection 4Patient Reported Outcome Measures 3sacituzumab govitecan 2Trastuzumab 2Surgical Procedures, Operative 2Quality of Life 2Physical Examination 2Phlebotomy 2Perfusion Magnetic Resonance Imaging 2Lead 2Lapatinib 2Interviews as Topic 2Immunotherapy 2Drug Therapy 2Data Collection 2Brain Mapping 2Bevacizumab 2Amplified Fragment Length Polymorphism Analysis 2Aminolevulinic Acid 2trastuzumab deruxtecan 1pembrolizumab 1osimertinib 1lorlatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Brain Neoplasms × Aminolevulinic Acid × Clear all
NCT05850377 2023-05-09

5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas

Sociedad de Lucha Contra el Cáncer del Ecuador

Not yet recruiting
90 enrolled
CNS

Brain Neoplasms, Glioma, Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Neoplasms, Neuroepithelial, Neoplasm, Residual

NCT04055688 2022-05-31

Novel Exoscope System for 5-ALA Fluorescence-Guided Surgery for Gliomas

H. Lee Moffitt Cancer Center and Research Institute

Completed
20 enrolled
CNS

Brain Neoplasms, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡